Published in J Neuropathol Exp Neurol on January 01, 1996
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol (2009) 11.05
Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron (2014) 2.83
Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline. N Engl J Med (2015) 1.97
Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A (1997) 1.89
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol (1999) 1.60
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet (2012) 1.58
Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci (2011) 1.42
Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. Am J Pathol (2003) 1.34
Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain (2011) 1.18
Late-onset neurodegenerative diseases--the role of protein insolubility. J Anat (2000) 1.07
Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. Am J Pathol (2006) 0.91
Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry (1998) 0.88
Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update. J Neurol (1999) 0.88
Phenotypic variation of autosomal-dominant corticobasal degeneration. Eur Neurol (2012) 0.81
Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases. J Neural Transm (Vienna) (2007) 0.80
Glial Tau Pathology in Tauopathies: Functional Consequences. J Exp Neurosci (2016) 0.79
Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol (2015) 0.79
Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm (Vienna) (1997) 0.77
Prion-like Spreading in Tauopathies. Biol Psychiatry (2017) 0.75
Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem (2016) 0.75
Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Mol Neurodegener (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol (1999) 2.73
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia (1993) 2.51
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
Cockayne syndrome and xeroderma pigmentosum. Neurology (2000) 2.24
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology (2004) 2.12
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Pathology and biology of the Lewy body. J Neuropathol Exp Neurol (1993) 1.99
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
Medulloblastoma with glial and rhabdomyoblastic differentiation. A myoglobin and glial fibrillary acidic protein immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol (1983) 1.88
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience (2007) 1.86
Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides. Am J Pathol (1985) 1.84
Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology (2006) 1.81
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (2000) 1.79
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am J Pathol (1985) 1.77
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol (1996) 1.71
Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol (1990) 1.67
Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Am J Pathol (1987) 1.66
Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest (1991) 1.60
Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol (1996) 1.60
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis (2010) 1.60
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology (2011) 1.59
A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease. Neurology (1994) 1.55
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (1989) 1.52
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (1986) 1.50
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol (1993) 1.48
Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (1990) 1.48
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl (2006) 1.46
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase (2005) 1.41
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (2000) 1.41
Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol (1994) 1.40
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol (1990) 1.40
Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol (2001) 1.40
Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest (1992) 1.39
Suppression of Meloidogyne arenaria Race 1 by Soil Application of Endospores of Pasteuria penetrans. J Nematol (1996) 1.35
Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol (1991) 1.34
Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol (1995) 1.32
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Morphological and Molecular Characterization of Meloidogyne mayaguensis Isolates from Florida. J Nematol (2004) 1.30
Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol (2003) 1.29
Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28
Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathol (1990) 1.28
Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology (2009) 1.27
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
Effect of Tropical Rotation Crops on Meloidogyne incognita and Other Plant-Parasitic Nematodes. J Nematol (1995) 1.27
Cryptococcus neoformans survive and replicate in human microglia. Lab Invest (1995) 1.26
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology (2010) 1.25
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology (2006) 1.24
Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease. Acta Neuropathol (1990) 1.23
Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology (2005) 1.23
Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol (2001) 1.21
A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. Neuropediatrics (1989) 1.21
'Candidatus pasteuria usgae' sp. nov., an obligate endoparasite of the phytoparasitic nematode Belonolaimus longicaudatus. Int J Syst Evol Microbiol (2003) 1.20
Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am J Pathol (1996) 1.20
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology (2011) 1.19
AIDS: calcification of the basal ganglia in infants and children. Neurology (1986) 1.18
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol (2003) 1.18
Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med (1994) 1.17
Multinucleated giant cells in acquired immunodeficiency syndrome encephalopathy. Origin from endogenous microglia? Arch Pathol Lab Med (1986) 1.17
Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol (1994) 1.16
Review of Pasteuria penetrans: Biology, Ecology, and Biological Control Potential. J Nematol (1998) 1.13
Tau gene mutation in familial progressive subcortical gliosis. Nat Med (1999) 1.13
Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology (2003) 1.13
A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration. Acta Neuropathol (1987) 1.13
Characterization of DCTN1 genetic variability in neurodegeneration. Neurology (2009) 1.11
GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia (1994) 1.10
Immunohistochemical localization of an HIV epitope in cerebral aneurysmal arteriopathy in pediatric acquired immunodeficiency syndrome (AIDS). Pediatr Pathol (1989) 1.10
Temperature-Dependent Development of Pasteuria penetrans in Meloidogyne arenaria. J Nematol (1997) 1.10
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med (2006) 1.10
Microglia in Alzheimer's disease and transgenic models. How close the fit? Am J Pathol (1999) 1.09
Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology (2010) 1.08
Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology (2003) 1.08
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging (1998) 1.08
Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology (2008) 1.07
Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick disease. Acta Neuropathol (1991) 1.07